Skip to main content
. 2021 Dec 18;21:604. doi: 10.1186/s12872-021-02411-w

Table 2.

Preoperative characteristics of matched patients undergone complex valve surgery

DN (n = 73) HTK (n = 73) P-value
Male gender [n(%)] 46 (63.0) 44 (60.3) 0.734
Age [P50(P25,P75), year] 56 (47,64) 56 (48,62) 0.677
Weight [P50(P25,P75), kg] 60 (52,65) 61 (54,73) 0.324
BMI 22 (20,25) 23 (21,25) 0.215
Arrhythmia [n(%)] 21 (28.8) 19 (26.0) 0.711
Poor cardiac function(NYHA grade3 to 4) [n(%)] 26 (35.6) 24 (32.9) 0.727
Previous myocardial infarction [n(%)] 1 (1.4) 2 (2.7) 0.560
Previous cardiac surgery [n(%)] 9 (12.3) 8 (10.9) 0.796
Coronary artery disease [n(%)] 24 (43.8) 25 (34.2) 0.841
Infective endocarditis [n(%)] 11 (15.1) 4 (5.5) 0.056
Hypertension [n(%)] 23 (31.5) 27 (37.0) 0.485
Diabetes [n(%)] 5 (6.8) 6 (8.2) 0.754
Previous stroke [n(%)] 7 (9.6) 7 (9.6) 1.000
Pulmonary disease [n(%)] 11 (15.1) 11 (15.1) 1.000
Preoperative CK-MB [P50(P25,P75), U/L] 11.0 (8.9,11.1) 13.0 (10,15.1) 0.070
Preoperative cTnI [P50(P25,P75), ng/mL] 0.02 (0.01,0.04) 0.02 (0.01,0.04) 0.727
Preoperative AST [P50(P25,P75), μu/L] 23.0 (18.0,29.3) 22.8 (18.8,31.3) 0.431
Preoperative creatinine [P50(P25,P75), μmol /L] 84.2 (73.1,94.5) 83 (74.8,100.8) 0.418
EuroSCORE II 4.08 (2.94,6.89) 4.30 (2.79,7.51) 0.902

DN, del Nido; HTK, histidine-tryptophan-ketoglutarate; NYHA, the New York Heart Association; CK-MB, creatine kinase myocardial isoenzyme; cTnI, cardiac troponin I; AST, serum aspartate transaminase